Liquidia Corporation (LQDA) Earnings Call Transcripts

46 earnings calls from March 2020 to June 16, 2026

NasdaqCM US Health Care Pharmaceuticals

Liquidia Corporation's Latest Earnings Call - June 16, 2026

The Liquidia Corporation's 2026 Annual Meeting primarily focused on procedural matters, including the election of directors and the ratification of the company's auditor. There were no discussions on revenue, earnings, or changes in guidance during the meeting. The meeting confirmed the election of Class II directors and the approval of executive compensation, but did not provide any new financial data or forward-looking guidance.

Reported metrics

MetricValueContext
Votes for David Johnson 44,874,399 (inline) Majority approval for election as Class II director
Votes for Katie Rielly-Gauvin 41,448,383 (inline) Majority approval for election as Class II director
Votes for Raman Singh 41,158,353 (inline) Majority approval for election as Class II director
Votes for Auditor Ratification 67,279,878 (inline) Approval of PricewaterhouseCoopers as auditor

What management said

Thank you, Sue. The report of the Inspector of Election indicates that these are -- that there are present at the meeting, virtually or represented by proxy, the holders of a majority of the total number of shares of the stock of the company outstanding and entitled to vote at the meeting. There is, therefore, a quorum present and the meeting is confident to transact business. Would the secretary of the meeting, plea...
— Roger Jeffs, June 16, 2026 earnings call

What analysts pressed on

There were no questions or concerns raised by analysts during the meeting, indicating a lack of immediate issues or controversies.

Main topics on the call

Read the full Liquidia Corporation transcript (June 16, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Liquidia Corporation

Liquidia Corporation (LQDA) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 46 calls on record spanning March 11, 2020 to June 16, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 46 Liquidia Corporation earnings call transcripts on record, spanning March 11, 2020 to June 16, 2026. Based on this history, Liquidia Corporation reports quarterly. The most recent call on file is dated June 16, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
LQDA
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
46
First call
March 11, 2020
Most recent
June 16, 2026
Reporting cadence
quarterly
Quarter Date
Shareholder/Analyst Calls Jun 16, 2026 Read transcript
Company Conference Presentations May 13, 2026 Read transcript
Q1 FY2026 May 11, 2026 Read transcript
Earnings Calls Mar 5, 2026 Read transcript
Company Conference Presentations Jan 15, 2026 Read transcript
Company Conference Presentations Nov 18, 2025 Read transcript
Company Conference Presentations Nov 10, 2025 Read transcript
Q3 FY2025 Nov 3, 2025 Read transcript
Special Calls Oct 28, 2025 Read transcript
Q2 FY2025 Aug 12, 2025 Read transcript
Special Calls May 27, 2025 Read transcript
Q1 FY2025 May 8, 2025 Read transcript
Company Conference Presentations Apr 8, 2025 Read transcript
Earnings Calls Mar 19, 2025 Read transcript
Company Conference Presentations Jan 15, 2025 Read transcript
Q3 FY2024 Nov 13, 2024 Read transcript
Q2 FY2024 Aug 7, 2024 Read transcript
Company Conference Presentations May 15, 2024 Read transcript
Q1 FY2024 May 14, 2024 Read transcript
Earnings Calls Mar 13, 2024 Read transcript
Company Conference Presentations Jan 10, 2024 Read transcript
Q3 FY2023 Nov 7, 2023 Read transcript
Q2 FY2023 Aug 10, 2023 Read transcript
Special Calls Jun 28, 2023 Read transcript
Company Conference Presentations May 9, 2023 Read transcript
Q1 FY2023 May 4, 2023 Read transcript
Earnings Calls Mar 16, 2023 Read transcript
Q3 FY2022 Nov 8, 2022 Read transcript
Special Calls Sep 1, 2022 Read transcript
Q2 FY2022 Aug 11, 2022 Read transcript
Shareholder/Analyst Calls Jun 16, 2022 Read transcript
Q1 FY2022 May 12, 2022 Read transcript
Q4 FY2021 Mar 17, 2022 Read transcript
Special Calls Nov 8, 2021 Read transcript
Q2 FY2021 Aug 10, 2021 Read transcript
Shareholder/Analyst Calls Jun 17, 2021 Read transcript
Q1 FY2021 May 13, 2021 Read transcript
Earnings Calls Mar 23, 2021 Read transcript
Special Calls Nov 25, 2020 Read transcript
Shareholder/Analyst Calls Nov 13, 2020 Read transcript
Q3 FY2020 Nov 9, 2020 Read transcript
Q2 FY2020 Aug 10, 2020 Read transcript
Special Calls Jun 30, 2020 Read transcript
Shareholder/Analyst Calls Jun 18, 2020 Read transcript
Q1 FY2020 May 11, 2020 Read transcript
Earnings Calls Mar 11, 2020 Read transcript